163 related articles for article (PubMed ID: 28402278)
21. The Expression and Prognostic Roles of MCMs in Pancreatic Cancer.
Peng YP; Zhu Y; Yin LD; Zhang JJ; Guo S; Fu Y; Miao Y; Wei JS
PLoS One; 2016; 11(10):e0164150. PubMed ID: 27695057
[TBL] [Abstract][Full Text] [Related]
22. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
Zhang Y; Dang C; Ma Q; Shimahara Y
Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
[TBL] [Abstract][Full Text] [Related]
23. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value and clinicopathological features of PD-1/PD-L1 expression with mismatch repair status and desmoplastic stroma in Chinese patients with pancreatic cancer.
Wang Y; Lin J; Cui J; Han T; Jiao F; Meng Z; Wang L
Oncotarget; 2017 Feb; 8(6):9354-9365. PubMed ID: 28030840
[TBL] [Abstract][Full Text] [Related]
25. Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer.
Maurer GD; Leupold JH; Schewe DM; Biller T; Kates RE; Hornung HM; Lau-Werner U; Post S; Allgayer H
Clin Cancer Res; 2007 Feb; 13(4):1123-32. PubMed ID: 17317820
[TBL] [Abstract][Full Text] [Related]
26. SP1 Expression and the Clinicopathological Features of Tumors: A Meta-Analysis and Bioinformatics Analysis.
Gao Y; Gan K; Liu K; Xu B; Chen M
Pathol Oncol Res; 2021; 27():581998. PubMed ID: 34257529
[No Abstract] [Full Text] [Related]
27. Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients.
Lee SH; Kim H; Hwang JH; Lee HS; Cho JY; Yoon YS; Han HS
Pathol Int; 2012 Mar; 62(3):167-75. PubMed ID: 22360504
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-215 functions as a tumor suppressor and directly targets ZEB2 in human pancreatic cancer.
Li QW; Zhou T; Wang F; Jiang M; Liu CB; Zhang KR; Zhou Q; Tian Z; Hu KW
Genet Mol Res; 2015 Dec; 14(4):16133-45. PubMed ID: 26662405
[TBL] [Abstract][Full Text] [Related]
29. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
[TBL] [Abstract][Full Text] [Related]
30. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.
Guo S; Jing W; Hu X; Zhou X; Liu L; Zhu M; Yin F; Chen R; Zhao J; Guo Y
Int J Cancer; 2014 Mar; 134(6):1369-78. PubMed ID: 24037692
[TBL] [Abstract][Full Text] [Related]
31. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
32. Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma.
Zhang H; Gao H; Liu C; Kong Y; Wang C; Zhang H
Diagn Pathol; 2015 Mar; 10():13. PubMed ID: 25890028
[TBL] [Abstract][Full Text] [Related]
33. Proteasome activator subunit 3 promotes pancreatic cancer growth via c-Myc-glycolysis signaling axis.
Guo J; Hao J; Jiang H; Jin J; Wu H; Jin Z; Li Z
Cancer Lett; 2017 Feb; 386():161-167. PubMed ID: 27756569
[TBL] [Abstract][Full Text] [Related]
34. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M
Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718
[TBL] [Abstract][Full Text] [Related]
35. Clinical implication of Sox9 and activated Akt expression in pancreatic ductal adenocarcinoma.
Xia S; Feng Z; Qi X; Yin Y; Jin J; Wu Y; Wu H; Feng Y; Tao M
Med Oncol; 2015 Jan; 32(1):358. PubMed ID: 25428381
[TBL] [Abstract][Full Text] [Related]
36. Expression of Coiled-Coil Domain Containing 34 (CCDC34) and its Prognostic Significance in Pancreatic Adenocarcinoma.
Qi W; Shao F; Huang Q
Med Sci Monit; 2017 Dec; 23():6012-6018. PubMed ID: 29257799
[TBL] [Abstract][Full Text] [Related]
37. Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer.
Nishiwada S; Sho M; Yasuda S; Shimada K; Yamato I; Akahori T; Kinoshita S; Nagai M; Konishi N; Nakajima Y
J Exp Clin Cancer Res; 2015 Mar; 34(1):30. PubMed ID: 25888293
[TBL] [Abstract][Full Text] [Related]
38. Elevated Transient Receptor Potential Melastatin 8 (TRPM8) Expression Is Correlated with Poor Prognosis in Pancreatic Cancer.
Du JD; Zheng X; Chen YL; Huang ZQ; Cai SW; Jiao HB; Zhu ZM; Hu B
Med Sci Monit; 2018 Jun; 24():3720-3725. PubMed ID: 29860264
[TBL] [Abstract][Full Text] [Related]
39. Collapsin response mediator protein 4 expression is associated with liver metastasis and poor survival in pancreatic cancer.
Hiroshima Y; Nakamura F; Miyamoto H; Mori R; Taniguchi K; Matsuyama R; Akiyama H; Tanaka K; Ichikawa Y; Kato S; Kobayashi N; Kubota K; Nagashima Y; Goshima Y; Endo I
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S369-78. PubMed ID: 22805864
[TBL] [Abstract][Full Text] [Related]
40. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
